newsfilter
← Latest News
Business Wire·

Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone

  • Sensus Healthcare, Inc. announced the sale of its 1,000th superficial radiotherapy (SRT) system for non-melanoma skin cancer treatment.
  • The milestone reflects growing physician adoption & expanded patient access to non-invasive alternatives to surgical excision.
  • Dedicated CPT codes implemented in January 2026 have provided greater reimbursement clarity & support broader commercial adoption.
  • The company is driving growth through physician education, flexible acquisition models, & commercial initiatives targeting dermatology practices.
  • CEO Joseph C. Sardano expressed confidence in the company's vision to make SRT widely available while targeting the next 1,000 unit sales.
  • Forward-looking statements in the release highlight risks including reimbursement levels, geopolitical tensions with China, & potential competition from new technologies.